Eribulin in Heavily Pre-Treated Metastatic Breast Cancer: A Case Series
Background: Treatment options are limited for heavily pre-treated metastatic breast cancer patients, with Eribulin showing promise in improving survival outcomes. Objective: To evaluate Eribulin outcomes in patients with MBC. Metastatic or incurable diseases are observed in 4% to 10% of women despi...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitas Padjadjaran
2025-04-01
|
| Series: | International Journal of Integrated Health Sciences |
| Subjects: | |
| Online Access: | https://journal.fk.unpad.ac.id/index.php/ijihs/article/view/3908 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|